Insider trading

Period: 12 months Type of trade: Sold × Minimum amount: $100K × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

32,808 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

32,808 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

32,808 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

32,808 decisions over 12 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
32,808 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
32,808 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

32,808 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
4 Nov 2025
Urdang E Scott Director
Sold at will
$181.96K 4,000 at 45.49
3.0%
Not planned
4 Nov 2025
CALLICUTT JACK W Chief Financial Officer
Sold on a plan 3×
$173.78K 28,629 at 6.07
79.0%
Sold half or more
4 Nov 2025
Hasson Heather L. Executive Chair
Sold on a plan
$172.53K 23,356 at 7.39
1.8%
Planned (10b5-1)
4 Nov 2025
GADICKE ANSBERT 10% owner · indirect
Sold on a plan
$171.40K 140,488 at 1.22
2.3%
Planned (10b5-1)
4 Nov 2025
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold on a plan
$171.40K 140,488 at 1.22
2.3%
Planned (10b5-1)
4 Nov 2025
Oughtred Sarah Chief Financial Officer
Sold on a plan
$168.02K 22,745 at 7.39
2.6%
Planned (10b5-1)
4 Nov 2025
Remer Eric Richard Chief Executive Officer
Sold on a plan
$152.47K 13,534 at 11.27
0.5%
Planned (10b5-1)
4 Nov 2025
BENDHEIM JACK President and CEO · indirect
Sold on a plan 2×
$151.70K 3,520 at 43.10
5.1%
Planned (10b5-1)
4 Nov 2025
Mehta Satish Chief Technology Officer
Sold on a plan
$151.56K 4,642 at 32.65
2.0%
Planned (10b5-1)
4 Nov 2025
Schuck Nicolas G Corp VP, Controller & CAO
Sold at will
$146.39K 466 at 314.36
16.1%
Not planned
4 Nov 2025
McKenzie Isabelle Vice President
Sold at will
$141.55K 3,200 at 44.24
6.8%
Not planned
4 Nov 2025
Newton Nikki Farentino President, Private Wealth Mgmt
Sold at will
$137.92K 1,300 at 106.09
8.7%
Not planned
4 Nov 2025
Malik Fady Ibraham EVP Research & Development
Sold on a plan
$136.67K 2,295 at 59.55
1.6%
Planned (10b5-1)
4 Nov 2025
Gambale Virginia Director
Sold at will
$133.96K 3,875 at 34.57
12.6%
Not planned
4 Nov 2025
Naude Pierre Director
Sold at will
$125.99K 4,881 at 25.81
0.4%
Not planned
4 Nov 2025
Rieger April Chief Lgl. & Admin Ofc., Sec
Sold at will
$122.12K 4,731 at 25.81
2.0%
Not planned
4 Nov 2025
LOVELAND CURTIS A Assistant Secretary
Sold at will
$115.20K 4,000 at 28.80
3.8%
Not planned
4 Nov 2025
Orenstein Gregory CFO & Treasurer
Sold at will
$112.36K 4,353 at 25.81
0.9%
Not planned
4 Nov 2025
EVNIN LUKE Director · indirect
Sold on a plan
$110.00K 90,164 at 1.22
2.3%
Planned (10b5-1)
4 Nov 2025
Reynoso Jamie L. CEO, Medicare Advantage
Sold on a plan
$108.78K 30,385 at 3.58
1.1%
Planned (10b5-1)
4 Nov 2025
Golden Robert Director · indirect
Sold at will
$106.25K 5,000 at 21.25
5.8%
Not planned
3 Nov 2025
Sold at will 24×
$266.65M 300,000 at 888.83
0.3%
Not planned
3 Nov 2025
Sold at will
$40.65M 2,500,000 at 16.26
9.7%
Not planned
3 Nov 2025
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan 3×
$32.13M 160,703 at 199.96
52.6%
Sold half or more
3 Nov 2025
Klarich Lee EVP Chief Product & Tech Ofcr
Sold on a plan 6×
$26.32M 120,774 at 217.94
25.3%
Planned (10b5-1)
3 Nov 2025
MITTS HEATH A EVP & Chief Financial Officer
Sold at will 4×
$20.34M 82,300 at 247.15
64.4%
Sold half or more
3 Nov 2025
SMITH BRADFORD L Vice Chair and President
Sold at will 2×
$19.97M 38,500 at 518.64
7.7%
Not planned
3 Nov 2025
Silverman David M Senior VP, Human Resources
Sold at will
$16.94M 120,000 at 141.17
90.6%
Sold half or more
3 Nov 2025
Xie Ken PRESIDENT & CEO
Sold on a plan 3×
$13.71M 158,485 at 86.51
0.3%
Planned (10b5-1)
3 Nov 2025
TABUTEAU HERRIOT Chief Executive Officer
Sold on a plan
$12.14M 91,705 at 132.34
92.7%
Sold half or more
3 Nov 2025
Tang Stanley Director · indirect
Sold on a plan 15×
$11.10M 45,410 at 244.39
100%
Sold half or more
3 Nov 2025
FRANKLIN MARTIN E Director · indirect
Sold on a plan 2×
$10.86M 300,000 at 36.19
1.5%
Planned (10b5-1)
3 Nov 2025
Pomel Olivier Chief Executive Officer
Sold on a plan 5×
$10.27M 62,682 at 163.90
10.5%
Planned (10b5-1)
3 Nov 2025
BENKOWITZ MICHAEL PRESIDENT AND COO · indirect
Sold on a plan 11×
$9.66M 22,500 at 429.25
100%
Sold half or more
3 Nov 2025
Bar-Zeev Tomer Director · indirect
Sold on a plan 2×
$9.49M 250,000 at 37.98
16.1%
Planned (10b5-1)
3 Nov 2025
Sold at will
$8.63M 250,000 at 34.51
24.0%
Not planned
3 Nov 2025
Armstrong Brian Chairman and CEO · indirect
Sold on a plan 6×
$8.44M 25,000 at 337.49
97.9%
Sold half or more
3 Nov 2025
Fang Andy Director · indirect
Sold on a plan 14×
$7.33M 30,000 at 244.39
100%
Sold half or more
3 Nov 2025
Meaney William L President and CEO
Sold on a plan 3×
$7.10M 69,125 at 102.75
100%
Sold half or more
3 Nov 2025
Sold at will 2×
$6.87M 45,266 at 151.70
57.1%
Sold half or more
3 Nov 2025
Yuan Eric S. Chief Executive Officer · indirect
Sold on a plan 4×
$6.32M 73,378 at 86.15
100%
Sold half or more
3 Nov 2025
Jenkins John S EVP & General Counsel
Sold at will 3×
$6.20M 25,021 at 247.73
54.5%
Sold half or more
3 Nov 2025
Kress Colette EVP & Chief Financial Officer
Sold on a plan 5×
$5.76M 27,640 at 208.33
1.0%
Planned (10b5-1)
3 Nov 2025
Sold on a plan 13×
$5.26M 20,000 at 262.82
4.1%
Planned (10b5-1)
3 Nov 2025
Weening Michael President & CEO
Sold on a plan
$4.99M 74,000 at 67.42
82.1%
Sold half or more
3 Nov 2025
Smith Michael Alexander Chief Legal Officer
Sold on a plan 8×
$4.99M 27,130 at 183.78
33.1%
Planned (10b5-1)
3 Nov 2025
Fitzgerald Joseph Michael EVP & Group Pres, Cardiology
Sold on a plan 3×
$4.97M 50,000 at 99.47
21.9%
Planned (10b5-1)
3 Nov 2025
MONDELLO MARK T Executive Chairman
Sold on a plan 6×
$4.42M 20,000 at 220.83
1.6%
Planned (10b5-1)
3 Nov 2025
Kress Colette EVP & Chief Financial Officer · indirect
Sold on a plan 10×
$4.17M 20,000 at 208.33
14.0%
Planned (10b5-1)
3 Nov 2025
JENKINS MARK W. Chief Financial Officer
Sold on a plan 26×
$4.12M 12,750 at 323.35
5.8%
Planned (10b5-1)
Showing 31,751–31,800 of 32,808. ← Newer Page 636 of 657 Older →